TG Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	386.39	329	233.66	2.79	6.69	0.15	Upgrade
Revenue Growth (YoY)	33.54%	40.80%	8290.02%	-58.36%	4300.66%	-	Upgrade
Cost of Revenue	48.59	38.49	14.13	0.27	0.79	-	Upgrade
Gross Profit	337.8	290.52	219.53	2.52	5.9	0.15	Upgrade
Selling, General & Admin	170.93	154.3	122.71	95.48	128.09	107.85	Upgrade
Research & Development	107.05	94.29	76.19	125.35	222.58	165.9	Upgrade
Operating Expenses	277.98	248.59	198.9	220.84	350.67	273.75	Upgrade
Operating Income	59.82	41.93	20.63	-218.32	-344.77	-273.59	Upgrade
Interest Expense	-28.5	-24.03	-12.62	-10.19	-5.64	-6.33	Upgrade
Other Non Operating Income (Expenses)	10.42	7.69	5.04	4.7	2.31	0.54	Upgrade
Pretax Income	41.74	25.59	13.06	-223.81	-348.1	-279.38	Upgrade
Income Tax Expense	2.59	2.21	0.39	-	-	-	Upgrade
Net Income	39.15	23.38	12.67	-223.81	-348.1	-279.38	Upgrade
Net Income to Common	39.15	23.38	12.67	-223.81	-348.1	-279.38	Upgrade
Net Income Growth	-4.97%	84.52%	-	-	-	-	Upgrade
Shares Outstanding (Basic)	145	145	142	135	132	115	Upgrade
Shares Outstanding (Diluted)	164	160	149	135	132	115	Upgrade
Shares Change (YoY)	9.66%	7.96%	9.67%	2.41%	14.64%	30.51%	Upgrade
EPS (Basic)	0.27	0.16	0.09	-1.65	-2.63	-2.42	Upgrade
EPS (Diluted)	0.24	0.15	0.09	-1.65	-2.63	-2.42	Upgrade
EPS Growth	-14.74%	68.03%	-	-	-	-	Upgrade
Free Cash Flow	-	-40.56	-31.41	-176.18	-296.04	-214.86	Upgrade
Free Cash Flow Per Share	-	-0.25	-0.21	-1.30	-2.24	-1.86	Upgrade
Gross Margin	87.43%	88.30%	93.95%	90.48%	88.19%	100.00%	Upgrade
Operating Margin	15.48%	12.74%	8.83%	-7838.99%	-5154.28%	-179996.05%	Upgrade
Profit Margin	10.13%	7.11%	5.42%	-8036.34%	-5204.08%	-183803.29%	Upgrade
Free Cash Flow Margin	-	-12.33%	-13.44%	-6326.18%	-4425.70%	-141357.90%	Upgrade
EBITDA	59.88	42	20.84	-218.01	-344.49	-273.44	Upgrade
EBITDA Margin	15.50%	12.77%	8.92%	-	-	-	Upgrade
D&A For EBITDA	0.06	0.07	0.21	0.3	0.28	0.16	Upgrade
EBIT	59.82	41.93	20.63	-218.32	-344.77	-273.59	Upgrade
EBIT Margin	15.48%	12.74%	8.83%	-	-	-	Upgrade
Effective Tax Rate	6.21%	8.64%	2.99%	-	-	-	Upgrade
Revenue as Reported	386.39	329	233.66	2.79	6.69	0.15	Upgrade

Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q